News Releases

Date	Title
09/03/2024	Heron Therapeutics Announces Appointment of Brett Fleshman as Chief Business Officer
08/06/2024	Heron Therapeutics Announces Second Quarter 2024 Financial Results and Narrows Financial Guidance
07/30/2024	Heron Therapeutics to Report Second Quarter 2024 Financial Results On Tuesday, August 6, 2024
07/15/2024	Heron Therapeutics Announces the Inclusion of ZYNRELEF® as a Qualifying Product Under the Proposed 2025 Non-Opioid Policy for Pain Relief Under the OPPS and the ASC Payment System
07/02/2024	Heron Therapeutics Announces Acceptance of the Prior Approval Supplement Application for ZYNRELEF® Vial Access Needle ("VAN")
05/29/2024	Heron Therapeutics Announces Prior Approval Supplement Submission to the FDA for ZYNRELEF® Vial Access Needle ("VAN")
05/07/2024	Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates
04/24/2024	Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
04/11/2024	Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City
03/28/2024	Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference

Keyword Search